These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9146613)
1. Prostate specific antigen. Benson MC J Urol; 1997 Jun; 157(6):2197-8. PubMed ID: 9146613 [No Abstract] [Full Text] [Related]
2. Re: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. Elgamal AA; Baert L J Urol; 1998 Mar; 159(3):994-5. PubMed ID: 9474213 [No Abstract] [Full Text] [Related]
6. [Prostatic specific antigen in practice in 1997]. Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634 [TBL] [Abstract][Full Text] [Related]
7. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point. Ablin RJ Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362 [No Abstract] [Full Text] [Related]
8. The role of prostate specific antigen in screening and management of clinically localized prostate cancer. Guru K; Tewari A; Hemal AK; Wei J; Javidan J; Peabody J; Menon M Int Urol Nephrol; 2003; 35(1):107-13. PubMed ID: 14620298 [No Abstract] [Full Text] [Related]
9. [The prostate specific antigen: what can we learn from the American experience?]. Zhao XJ Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833 [No Abstract] [Full Text] [Related]
10. [PSA based screening for prostatic cancer]. Johansen TE Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357 [No Abstract] [Full Text] [Related]
11. Biopsy diagnosis of prostatic cancer--current areas of concern. Feneley MR; Parkinson MC J Clin Pathol; 1997 Apr; 50(4):265-6. PubMed ID: 9215135 [No Abstract] [Full Text] [Related]
12. Best screening tests for prostate cancer. Moul JW West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692 [No Abstract] [Full Text] [Related]
13. PSA screening: the bottom line. Elhilali MM CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466 [No Abstract] [Full Text] [Related]
14. Screening by the prostate-specific antigen test: what do the patients know? Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154 [TBL] [Abstract][Full Text] [Related]
15. Controversy in clinical cancer screening--prostate-specific antigen. McKay DA West J Med; 1994 Jul; 161(1):58-9. PubMed ID: 7524244 [No Abstract] [Full Text] [Related]
16. Prostate cancer screening is experimental. Cox B N Z Med J; 1996 Mar; 109(1017):63-4. PubMed ID: 8606819 [No Abstract] [Full Text] [Related]
17. Screening for prostate cancer remains controversial. Neal DE; Donovan JL; Martin RM; Hamdy FC Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817 [No Abstract] [Full Text] [Related]
19. PSA screening. Cohen S; Schiff S; Kelty P Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782 [No Abstract] [Full Text] [Related]
20. The new data on prostate cancer screening: what should we do now? Gilligan T Cleve Clin J Med; 2009 Aug; 76(8):446-8. PubMed ID: 19652037 [No Abstract] [Full Text] [Related] [Next] [New Search]